Intensity Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INTS and other ETFs, options, and stocks.About INTS
Intensity Therapeutics, Inc. operates as biotechnology company, which develops novel immune-based therapeutic products for cancer treatment. Its product, INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine.
CEOLewis H. Bender
CEOLewis H. Bender
Employees16
Employees16
HeadquartersShelton, Connecticut
HeadquartersShelton, Connecticut
Founded2012
Founded2012
Employees16
Employees16
INTS Key Statistics
Market cap5.89M
Market cap5.89M
Price-Earnings ratio-0.30
Price-Earnings ratio-0.30
Dividend yield—
Dividend yield—
Average volume3.48M
Average volume3.48M
High today$0.3399
High today$0.3399
Low today$0.3031
Low today$0.3031
Open price$0.32
Open price$0.32
Volume786.20K
Volume786.20K
52 Week high$5.10
52 Week high$5.10
52 Week low$0.2845
52 Week low$0.2845
People also own
Based on the portfolios of people who own INTS. This list is generated using Robinhood data, and it’s not a recommendation.